Health-related quality of life and symptoms in patients with myelofibrosis treated with ruxolitinib versus best available therapy

Claire N. Harrison, Ruben A. Mesa, Jean Jacques Kiladjian, Haifa Kathrin Al-Ali, Heinz Gisslinger, Laurent Knoops, Margaret Squier, Andres Sirulnik, Estella Mendelson, Xiaolei Zhou, Catherine Copley-Merriman, Deborah S. Hunter, Richard S. Levy, Francisco Cervantes, Francesco Passamonti, Tiziano Barbui, Giovanni Barosi, Alessandro M. Vannucchi

Research output: Contribution to journalArticle

55 Scopus citations

Fingerprint Dive into the research topics of 'Health-related quality of life and symptoms in patients with myelofibrosis treated with ruxolitinib versus best available therapy'. Together they form a unique fingerprint.

Medicine & Life Sciences